AR and triple-negative breast carcinoma: Lehmann and colleagues identified a subtype of triple-negative breast cancer (TNBC) characterized by the presence of the androgen receptor (AR) and expression of other luminal genes termed the luminal-androgen receptor (LAR) subtype.